Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Anti-G17 immunogen (formerly Gastrimmune): Began Phase III trial

Aphton Corp. (APHT), Miami, Fla.
Product: Anti-G17

Read the full 79 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE